Front Row Advisors LLC Horizon Therapeutics Public LTD CO Transaction History

Front Row Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	BUY	$62.39 - $113.8 $686 - $1,251	11 Added 11.58%	106 $12,000
Q3 2022 Nov 15, 2022	SELL	$58.92 - $84.67 $412 - $592	-7 Reduced 6.86%	95 $6,000
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $952 - $1,396	12 Added 13.33%	102 $8,000
Q4 2021 Mar 09, 2022	SELL	$98.56 - $119.91 $492 - $599	-5 Reduced 5.26%	90 $10,000
Q2 2021 Aug 23, 2021	SELL	$86.24 - $95.92 $86 - $95	-1 Reduced 1.04%	95 $10,000
Q1 2021 Apr 28, 2021	BUY	$71.83 - $95.48 $2,154 - $2,864	30 Added 45.45%	96 $9,000
Q4 2020 Feb 25, 2021	BUY	$67.0 - $84.39 $4,422 - $5,569	66 New	66 $5,000
Q3 2019 Nov 08, 2019	SELL	$23.0 - $27.97 $4,853 - $5,901	-211 Closed	0 $0
Q1 2019 May 17, 2019	BUY	$19.49 - $29.01 $4,112 - $6,121	211 New	211 $6,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Front Row Advisors LLC with notifications on news.